1887

Journal of General Virology header logo

Volume 81, Issue 5

Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness Free

Abstract

The Rev protein of equine infectious anaemia virus (EIAV) was shown previously to stimulate the expression of a heterologous CAT reporter gene when the 3′ half of the EIAV genome was present downstream . However, computer analysis could not reveal the existence of a stable RNA secondary structure that could be analogous to the Rev-responsive element of other lentiviruses. In the present study, the inhibitory RNA element designated the -acting repressing sequence (CRS) has been localized to the centre of the EIAV genome. The inhibition exerted by this element could be overcome by supplying Rev . The ability of the EIAV CRS to function in a heterologous context suggests that it does not require interactions with other viral proteins. Site-directed mutagenesis showed that the various centrally located suboptimal splice sites of the EIAV genome function as CRS and confer Rev-dependence on the CRS-containing transcripts. In addition, the data suggest that in canine Cf2Th cells, which are highly permissive for EIAV replication, CRS prevents nuclear export of CRS-containing transcripts and the supply of Rev relieves this suppression.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-5-1265
2000-05-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/5/0811265a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-5-1265&mimeType=html&fmt=ahah

References

  1. Belshan, M., Harris, M. E., Shoemaker, A. E., Hope, T. J. & Carpenter, S. (1998). Biological characterization of Rev variation in equine infectious anemia virus.Journal of Virology 72, 4421-4426. [Google Scholar]
  2. Borg, K. T., Favaro, J. P. & Arrigo, S. J. (1997). Involvement of human immunodeficiency virus type-1 splice sites in the cytoplasmic accumulation of viral RNA.Virology 236, 95-103.[CrossRef] [Google Scholar]
  3. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M. & Rosen, C. A. (1991). Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.Journal of Virology 65, 5305-5313. [Google Scholar]
  4. Cullen, B. R. (1998). Retroviruses as model systems for the study of nuclear RNA export pathways.Virology 249, 203-210.[CrossRef] [Google Scholar]
  5. Fridell, R. A., Partin, K. M., Carpenter, S. & Cullen, B. R. (1993). Identification of the activation domain of equine infectious anemia virus rev.Journal of Virology 67, 7317-7323. [Google Scholar]
  6. Gontarek, R. R. & Derse, D. (1996). Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.Molecular and Cellular Biology 16, 2325-2331. [Google Scholar]
  7. Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. & Howard, B. H. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.Proceedings of the National Academy of Sciences, USA 79, 6777-6781.[CrossRef] [Google Scholar]
  8. Harris, M. E., Gontarek, R. R., Derse, D. & Hope, T. J. (1998). Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.Molecular and Cellular Biology 18, 3889-3899. [Google Scholar]
  9. Huffman, K. M. & Arrigo, S. J. (1997). Identification of cis-acting repressor activity within human immunodeficiency virus type 1 protease sequences.Virology 234, 253-260.[CrossRef] [Google Scholar]
  10. Kawakami, T., Sherman, L., Dahlberg, J., Gazit, A., Yaniv, A., Tronick, S. R. & Aaronson, S. A. (1987). Nucleotide sequence analysis of equine infectious anemia proviral DNA.Virology 158, 300-312.[CrossRef] [Google Scholar]
  11. Kingsman, S. M. & Kingsman, A. J. (1996). The regulation of human immunodeficiency virus type-1 gene expression.European Journal of Biochemistry 240, 491-507.[CrossRef] [Google Scholar]
  12. Maldarelli, F., Martin, M. A. & Strebel, K. (1991). Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation.Journal of Virology 65, 5732-5743. [Google Scholar]
  13. Malim, M. H., Hauber, J., Fenrick, R. & Cullen, B. R. (1988). Immunodeficiency virus Rev trans-activator modulates the expression of the viral regulatory genes.Nature 335, 181-183.[CrossRef] [Google Scholar]
  14. Mancuso, V. A., Hope, T. J., Zhu, L., Derse, D., Phillips, T. & Parslow, T. G. (1994). Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.Journal of Virology 68, 1998-2001. [Google Scholar]
  15. Martarano, L., Stephens, R., Rice, N. & Derse, D. (1994). Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.Journal of Virology 68, 3102-3111. [Google Scholar]
  16. Meyer, B. E., Meinkoth, J. L. & Malim, M. H. (1996). Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals.Journal of Virology 70, 2350-2359. [Google Scholar]
  17. Neumann, J. R., Morency, C. A. & Russian, K. O. (1987). A novel rapid assay for chloramphenicol acetyltransferase gene expression.Biotechniques 5, 444-447. [Google Scholar]
  18. Noiman, S., Yaniv, A., Sherman, L., Tronick, S. R. & Gazit, A. (1990). Pattern of transcription of the genome of equine infectious anemia virus.Journal of Virology 64, 1839-1843. [Google Scholar]
  19. Noiman, S., Yaniv, A., Tsach, T., Miki, T., Tronick, S. R. & Gazit, A. (1991). The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts.Virology 184, 521-530.[CrossRef] [Google Scholar]
  20. Otero, G. C., Harris, M. E., Donello, J. E. & Hope, T. J. (1998). Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element.Journal of Virology 72, 7593-7597. [Google Scholar]
  21. Pollard, V. W. & Malim, M. H. (1998). The HIV-1 Rev protein.Annual Review of Microbiology 52, 491-532.[CrossRef] [Google Scholar]
  22. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G. & Haseltine, W. A. (1988). Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.Proceedings of the National Academy of Sciences, USA 85, 2071-2075.[CrossRef] [Google Scholar]
  23. Rosin-Arbesfeld, R., Rivlin, M., Noiman, S., Mashiah, P., Yaniv, A., Miki, T., Tronick, S. R. & Gazit, A. (1993). Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.Journal of Virology 67, 5640-5646. [Google Scholar]
  24. Rosin-Arbesfeld, R., Willbold, D., Yaniv, A. & Gazit, A. (1998). The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription.Gene 219, 25-35.[CrossRef] [Google Scholar]
  25. Schoborg, R. V. & Clements, J. E. (1996). Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein.Virology 226, 113-121.[CrossRef] [Google Scholar]
  26. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992a). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.Journal of Virology 66, 150-159. [Google Scholar]
  27. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K. & Pavlakis, G. N. (1992b). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.Journal of Virology 66, 7176-7182. [Google Scholar]
  28. Tan, W., Schalling, M., Zhao, C., Luukkonen, M., Nilsson, M., Fenyo, E. M., Pavlakis, G. N. & Schwartz, S. (1996). Inhibitory activity of the equine infectious anemia virus major 5’ splice site in the absence of Rev.Journal of Virology 70, 3645-3658. [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-5-1265
Loading
Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness
J. Gen. Virol. 81, 1265 (2000); https://doi.org/10.1099/0022-1317-81-5-1265
/content/journal/jgv/10.1099/0022-1317-81-5-1265
/content/journal/jgv/10.1099/0022-1317-81-5-1265
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error